Literature DB >> 15683762

Current approaches to the management of ovine footrot.

K A Abbott1, C J Lewis.   

Abstract

Ovine footrot remains the most important cause of lameness in sheep flocks in the UK, despite the existence of proven methods for the control of the disease. Recent research suggests that sheep farmers may be unaware of these methods and may allocate greater resources to treatment of footrot rather than to its prevention. Foot paring, topical treatments, vaccination and parenteral antibiotic therapy all have a role in treating sheep with advanced footrot infections, but prevention of severe infections is best achieved by the timely implementation of control programmes. These are usually based on footbathing and vaccination. For control programmes to be effective it is essential that the pathogenesis and epidemiology of footrot is understood and that control methods are implemented at appropriate times in the season, depending on climatic and pasture conditions. This article reviews these strategies and makes recommendations for steps to reduce the spread of footrot between flocks and to reduce the incidence of footrot within UK flocks.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683762     DOI: 10.1016/j.tvjl.2004.05.008

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  12 in total

1.  Identification of spirochetes associated with contagious ovine digital dermatitis.

Authors:  G Sayers; P X Marques; N J Evans; L O'Grady; M L Doherty; S D Carter; J E Nally
Journal:  J Clin Microbiol       Date:  2009-02-09       Impact factor: 5.948

2.  Breeding for resistance to footrot--the use of hoof lesion scoring to quantify footrot in sheep.

Authors:  J Conington; B Hosie; G J Nieuwhof; S C Bishop; L Bünger
Journal:  Vet Res Commun       Date:  2008-05-14       Impact factor: 2.459

3.  Ovine Footrot and Its Clinical Management.

Authors:  Haben Fesseha
Journal:  Vet Med (Auckl)       Date:  2021-05-11

4.  Co-induction of cyclooxygenase-2 [correction of cyclooxyenase-2] and early growth response gene (Egr-1) in spinal cord in a clinical model of persistent inflammation and hyperalgesia.

Authors:  Sharron Dolan; Peter Hastie; Claire Crossan; Andrea M Nolan
Journal:  Mol Pain       Date:  2011-11-23       Impact factor: 3.395

5.  Development and comparison of a real-time PCR assay for detection of Dichelobacter nodosus with culturing and conventional PCR: harmonisation between three laboratories.

Authors:  Sara Frosth; Jannice S Slettemeås; Hannah J Jørgensen; Oystein Angen; Anna Aspán
Journal:  Acta Vet Scand       Date:  2012-01-31       Impact factor: 1.695

6.  Possible cross-infection of Dichelobacter nodosus between co-grazing sheep and cattle.

Authors:  Torunn Rogdo; Lisbeth Hektoen; Jannice Schau Slettemeås; Hannah Joan Jørgensen; Olav Østerås; Terje Fjeldaas
Journal:  Acta Vet Scand       Date:  2012-03-29       Impact factor: 1.695

7.  Predicting Lameness in Sheep Activity Using Tri-Axial Acceleration Signals.

Authors:  Jamie Barwick; David Lamb; Robin Dobos; Derek Schneider; Mitchell Welch; Mark Trotter
Journal:  Animals (Basel)       Date:  2018-01-11       Impact factor: 2.752

8.  A Cross-Sectional Epizootiological Study and Risk Assessment of Foot-Related Lesions and Lameness in Intensive Dairy Sheep Farms.

Authors:  Marios Moschovas; Aphrodite I Kalogianni; Panagiotis Simitzis; Georgios Pavlatos; Stavros Petrouleas; Ioannis Bossis; Athanasios I Gelasakis
Journal:  Animals (Basel)       Date:  2021-05-29       Impact factor: 2.752

9.  An evaluation of the ability of Dichelobacter nodosus to survive in soil.

Authors:  Sara Ellinor Cederlöf; Tomas Hansen; Ilka Christine Klaas; Øystein Angen
Journal:  Acta Vet Scand       Date:  2013-01-23       Impact factor: 1.695

Review 10.  Aetiology, Risk Factors, Diagnosis and Control of Foot-Related Lameness in Dairy Sheep.

Authors:  Athanasios I Gelasakis; Aphrodite I Kalogianni; Ioannis Bossis
Journal:  Animals (Basel)       Date:  2019-07-31       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.